Ekama Sabdat Ozichu, Sheth Anandi N, Ilomuanya Margaret O, Okwuzu Jane Ogoamaka, Musa Adesola Zaidat, Idigbe Ifeoma, Ezeobi Paschal Mbanefo, Oladele David Ayoola, Ezechi Oliver Chukwujekwu, Salako Babatunde Lawal
Clinical Sciences Department, Nigerian Institute of Medical Research, Yaba, Lagos, P.M.B 2013, Nigeria.
Department of Medicine, Division of Infectious Diseases, Emory School of Medicine, Atlanta, GA, USA.
HIV AIDS (Auckl). 2025 Feb 1;17:19-28. doi: 10.2147/HIV.S468667. eCollection 2025.
Female sex workers have a 13-fold higher risk of acquiring HIV than women who do not engage in sex work. The willingness and acceptability of a product is crucial for the development of microbicides. This research aimed to evaluate the sexual practices, existing HIV prevention methods, and willingness to use a microbicide for HIV prevention among female sex workers in Nigeria. We also explored factors that might influence their willingness to use a new microbicide product.
A cross-sectional study was conducted among female sex workers recruited from brothels within Lagos-Nigeria, in which participants were selected via purposive sampling over a period of five-months. An interviewer-administered, semi-structured questionnaire was used to obtain information. Descriptive statistics were used to present the results, and a multiple logistic regression model was used to determine the factors associated with willingness to use a microbicide.
A total of 461 female participants with a mean-age of 29.63 ± 8.8 years were included in the analysis of which 34.3% had >4 sexual partners, 91.8% used condoms, 53.6% engaged in anal sex, 69.6% had experienced condom rupture, and 31% would "accept unprotected sex" if the male partner refuses to use a condom. Approximately 43% had received PEP, of which only 15% completed the one-month PEP-regimen. On the other hand, 64.6% had taken PrEP medications, of which 28% admitted skipping doses. Although 41% were concerned about male partner acceptance, a total of 95% will be willing to use a microbicide. The number of sexual partners ([aOR] 1.555; 95% Cl 1.035-2.335), use of condoms ([aOR] 4.701; 95% Cl 1.418-15.584), and condom rupture experience ([aOR] 2.550; 95% Cl 1.817-7.959) were associated with greater odds of willingness to use an HIV microbicide.
There is a high level of willingness to use a future microbicide among the female commercial sex workers in this study. In addition, majority of the participants will prefer a microbicide product that is female controlled, affordable, and provided as an over-the-counter medication. This cohort of women engage in high-risk sexual practices and play a significant role in HIV prevention efforts. Therefore, their product preferences and concerns should be considered in microbicide development to enhance the acceptability, adherence, and efficacy of future microbicides.
女性性工作者感染艾滋病毒的风险比不从事性工作的女性高13倍。产品的意愿性和可接受性对于杀微生物剂的开发至关重要。本研究旨在评估尼日利亚女性性工作者的性行为、现有的艾滋病毒预防方法以及使用杀微生物剂预防艾滋病毒的意愿。我们还探讨了可能影响她们使用新型杀微生物剂产品意愿的因素。
在尼日利亚拉各斯的妓院招募女性性工作者进行横断面研究,在五个月的时间里通过目的抽样选择参与者。使用由访谈员实施的半结构化问卷来获取信息。描述性统计用于呈现结果,多元逻辑回归模型用于确定与使用杀微生物剂意愿相关的因素。
共有461名女性参与者纳入分析,平均年龄为29.63±8.8岁,其中34.3%有超过4个性伴侣,91.8%使用避孕套,53.6%有肛交行为,69.6%经历过避孕套破裂,31%在男性伴侣拒绝使用避孕套时会“接受无保护性行为”。约43%接受过暴露后预防(PEP),其中只有15%完成了为期一个月的PEP疗程。另一方面,64.6%服用过暴露前预防(PrEP)药物,其中28%承认有漏服情况。尽管41%担心男性伴侣的接受度,但总共95%愿意使用杀微生物剂。性伴侣数量(调整后比值比[aOR] 1.555;95%置信区间[Cl] 1.035 - 2.335)、避孕套使用情况([aOR] 4.701;95% Cl 1.418 - 15.584)以及避孕套破裂经历([aOR] 2.550;95% Cl 1.817 - 7.959)与使用艾滋病毒杀微生物剂的意愿几率更高相关。
本研究中的女性商业性工作者对未来使用杀微生物剂有很高的意愿。此外,大多数参与者更喜欢女性可控、价格可承受且作为非处方药提供的杀微生物剂产品。这群女性从事高风险性行为,在艾滋病毒预防工作中发挥着重要作用。因此,在杀微生物剂开发中应考虑她们的产品偏好和担忧,以提高未来杀微生物剂的可接受性、依从性和有效性。